Clovis Oncology, Inc. Interest Expense on Debt
Clovis Oncology, Inc. reported Interest Expense on Debt of $9.86 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2022-11-09
- Clovis Oncology, Inc. interest expense, debt for the quarter ending 2022-09-30 was $9.86M, a 12.26% increase year-over-year.
- Clovis Oncology, Inc. interest expense, debt for the quarter ending 2022-06-30 was $9.67M, a 10.31% increase year-over-year.
- Clovis Oncology, Inc. interest expense, debt for the quarter ending 2022-03-31 was $9.10M, a 13.23% increase year-over-year.
- Clovis Oncology, Inc. interest expense, debt for the quarter ending 2021-12-31 was $8.51M, a 15.80% increase year-over-year.
- Clovis Oncology, Inc. interest expense, debt for fiscal 2021 was $34.10M, a 11.78% increase from fiscal 2020.
- Clovis Oncology, Inc. interest expense, debt for fiscal 2020 was $30.51M, a 57.22% increase from fiscal 2019.
- Clovis Oncology, Inc. interest expense, debt for fiscal 2019 was $19.41M, a 47.20% increase from fiscal 2018.
- Clovis Oncology, Inc. interest expense, debt for fiscal 2018 was $13.18M, a 26.42% increase from fiscal 2017.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $9.86M 10-Q · filed 2022-11-09 | $19.54M derived: sum of 2 quarters · filed 2022-11-09 | $28.64M 10-Q · filed 2022-11-09 | $37.15M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $9.67M 10-Q · filed 2022-08-08 | $18.77M 10-Q · filed 2022-08-08 | $27.28M derived: sum of 3 quarters · filed 2022-08-08 | $36.07M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $9.10M 10-Q · filed 2022-05-05 | $17.61M derived: sum of 2 quarters · filed 2022-05-05 | $26.40M derived: sum of 3 quarters · filed 2022-11-09 | $35.17M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $8.51M 10-K · filed 2022-02-24 | $17.30M derived: sum of 2 quarters · filed 2022-11-09 | $26.07M derived: sum of 3 quarters · filed 2022-11-09 | $34.10M 10-K · filed 2022-02-24 |
| 2021-09-30 | $8.79M 10-Q · filed 2022-11-09 | $17.56M derived: sum of 2 quarters · filed 2022-11-09 | $25.59M 10-Q · filed 2022-11-09 | $32.94M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $8.77M 10-Q · filed 2022-08-08 | $16.81M 10-Q · filed 2022-08-08 | $24.16M derived: sum of 3 quarters · filed 2022-08-08 | $31.02M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $8.04M 10-Q · filed 2022-05-05 | $15.39M derived: sum of 2 quarters · filed 2022-05-05 | $22.25M derived: sum of 3 quarters · filed 2022-05-05 | $28.98M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $7.35M 10-K · filed 2022-02-24 | $14.21M derived: sum of 2 quarters · filed 2022-02-24 | $20.95M derived: sum of 3 quarters · filed 2022-02-24 | $30.51M 10-K · filed 2022-02-24 |
| 2020-09-30 | $6.86M 10-K · filed 2022-02-24 | $13.60M derived: sum of 2 quarters · filed 2022-02-24 | $23.16M 10-Q · filed 2021-11-03 | $29.88M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $6.74M 10-K · filed 2022-02-24 | $16.30M 10-Q · filed 2021-08-04 | $23.02M derived: sum of 3 quarters · filed 2022-02-24 | $28.30M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $9.56M 10-K · filed 2022-02-24 | $16.28M derived: sum of 2 quarters · filed 2022-02-24 | $21.56M derived: sum of 3 quarters · filed 2022-02-24 | $25.38M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $6.72M 10-K · filed 2021-02-25 | $12.00M derived: sum of 2 quarters · filed 2021-02-25 | $15.81M derived: sum of 3 quarters · filed 2021-02-25 | $19.41M 10-K · filed 2022-02-24 |
| 2019-09-30 | $5.28M 10-K · filed 2021-02-25 | $9.10M derived: sum of 2 quarters · filed 2021-02-25 | $12.68M 10-Q · filed 2020-11-05 | $16.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $3.82M 10-K · filed 2021-02-25 | $7.41M 10-Q · filed 2020-08-07 | $11.00M derived: sum of 3 quarters · filed 2021-02-25 | $14.37M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $3.59M 10-K · filed 2021-02-25 | $7.18M derived: sum of 2 quarters · filed 2021-02-25 | $10.56M derived: sum of 3 quarters · filed 2021-02-25 | $14.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $3.59M 10-K · filed 2020-02-26 | $6.97M derived: sum of 2 quarters · filed 2020-02-26 | $10.55M derived: sum of 3 quarters · filed 2020-02-26 | $13.18M 10-K · filed 2021-02-25 |
| 2018-09-30 | $3.38M 10-K · filed 2020-02-26 | $6.96M derived: sum of 2 quarters · filed 2020-02-26 | $9.59M 10-Q · filed 2019-11-07 | $12.22M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $3.58M 10-K · filed 2020-02-26 | $6.22M 10-Q · filed 2019-08-02 | $8.85M derived: sum of 3 quarters · filed 2020-02-26 | $11.46M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $2.63M 10-K · filed 2020-02-26 | $5.27M derived: sum of 2 quarters · filed 2020-02-26 | $7.88M derived: sum of 3 quarters · filed 2020-02-26 | $10.48M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $2.63M 10-K · filed 2019-02-28 | $5.25M derived: sum of 2 quarters · filed 2019-02-28 | $7.85M derived: sum of 3 quarters · filed 2019-02-28 | $10.43M 10-K · filed 2020-02-26 |
| 2017-09-30 | $2.62M 10-K · filed 2019-02-28 | $5.22M derived: sum of 2 quarters · filed 2019-02-28 | $7.80M 10-Q · filed 2018-11-01 | $9.97M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $2.60M 10-K · filed 2019-02-28 | $5.18M 10-Q · filed 2018-08-02 | $7.35M derived: sum of 3 quarters · filed 2019-02-28 | $9.46M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $2.58M 10-K · filed 2019-02-28 | $4.75M derived: sum of 2 quarters · filed 2019-02-28 | $6.86M derived: sum of 3 quarters · filed 2019-02-28 | $8.97M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.17M 10-K · filed 2018-02-27 | $4.28M derived: sum of 2 quarters · filed 2018-02-27 | $6.39M derived: sum of 3 quarters · filed 2018-02-27 | $8.49M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.11M 10-K · filed 2018-02-27 | $4.21M derived: sum of 2 quarters · filed 2018-02-27 | $6.32M 10-Q · filed 2017-11-02 | $8.42M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.11M 10-K · filed 2018-02-27 | $4.21M 10-Q · filed 2017-08-03 | $6.31M derived: sum of 3 quarters · filed 2018-02-27 | $8.41M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.10M 10-K · filed 2018-02-27 | $4.21M derived: sum of 2 quarters · filed 2018-02-27 | $6.30M derived: sum of 3 quarters · filed 2018-02-27 | $8.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.10M 10-K · filed 2017-02-23 | $4.20M derived: sum of 2 quarters · filed 2017-02-23 | $6.30M derived: sum of 3 quarters · filed 2017-02-23 | $8.37M 10-K · filed 2018-02-27 |
| 2015-09-30 | $2.10M 10-K · filed 2017-02-23 | $4.20M derived: sum of 2 quarters · filed 2017-02-23 | $6.27M 10-Q · filed 2016-11-04 | $8.36M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $2.10M 10-K · filed 2017-02-23 | $4.17M 10-Q · filed 2016-08-09 | $6.26M derived: sum of 3 quarters · filed 2017-02-23 | $6.78M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $2.08M 10-K · filed 2017-02-23 | $4.17M derived: sum of 2 quarters · filed 2017-02-23 | $4.68M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | $2.09M 10-K · filed 2016-02-29 | $2.60M derived: sum of 2 quarters · filed 2016-02-29 | $2.60M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $511.00K 10-K · filed 2016-02-29 | $511.00K 10-Q · filed 2015-11-06 |